IFNG and tuberculosis: Finally, the crucial role of IFN-γ in human antimycobacterial immunity is highlighted by the efficacy of recombinant IFN-γ as a treatment in patients with nontuberculous mycobacterial diseases lacking a genetic diagnosis (33), MSMD (34, 35), and TB (32).